XV LVAS procedure is to be included in a key medical treatment reimbursement program in the United States. - in regards to this reimbursement when will we be able to see the amounts on the upcoming reports? Will it be this 28th of Feb? It said that the acquisition of Imbio will get to positive cash flow or revenue? Overall, we’ll be seeing positive inflow in the company this half yearly report? It’s just that 4DX has been quiet.
XV LVAS procedure is to be included in a key medical treatment...
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.005(0.90%) |
Mkt cap ! $217.2M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 56.0¢ | $13.59K | 24.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 62.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 3812 | 1 |
View Market Depth
| Last trade - 10.01am 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
57.5¢ |
Change
0.005 ( 1.82 %) |
||||
| Open | High | Low | Volume | ||
| 56.0¢ | 59.3¢ | 56.0¢ | 56035 | ||
| Last updated 10.28am 09/05/2024 ? | |||||
| 4DX (ASX) Chart |